CALIXAR’s technology maintains the structural and functional integrities of antigens yielding accurate recognition of specific antibodies which is ideal for immunoassays.
CALIXAR’s technology sustains the structural and functional integrities of the antigens providing accurate identification of specific antibodies.
Our best-in-class technology delivers high-quality native antigens to qualify immunoassays. Our technology is compatible with immunoassays such as ELISA, SPR, Proteomics.
CALIXAR’s immunoassays are particularly adapted for drug discovery scientists (Pharma, biotechs, academics) that are involved in cancer immunology, immuno-monitoring, virology, diagnostics, and antibody development.
CALIXAR’s technology maintains the structural and functional integrities of the antigens allowing sound recognition of specific antibodies.
Traditionally, immunoassays were conducted with low-quality antigens and assays variances (antigen’s buffer conditions).
However, CALIXAR offers high-quality, native, pure and functional antigens and employs patented technology and customized methods for each of our client’s immunoassay projects.
The CALIXAR® platform uses patented technologies only available for clients under specific agreements (license, co-development, and service).
You can leverage CALIXAR’s proprietary technology as well as other best-in-class membrane protein technology not available anywhere else on the market.